Question 1

What is the catalog number for IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued?

Accepted Answer

The catalog number for IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued is 219875.

Question 2

What sizes are available for IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued?

Accepted Answer

IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued is available in the following size(s): 10 µg.

Question 3

Is IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued in stock?

Accepted Answer

IGF-BP4, Recombinant, Human (Insulin-like Growth Factor-Binding Protein 4, IBP-4, HT29-IGF-BP, Colon Cancer Cell Growth Inhibitor) discontinued

Selected Variant

219875

Size: 10 µg

Product Specifications

No additional specifications available.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.